WO2023143474 - METHODS FOR TREATING GASTRIC CANCER
National phase entry is expected:
Publication Number
WO/2023/143474
Publication Date
03.08.2023
International Application No.
PCT/CN2023/073471
International Filing Date
25.01.2023
Title **
[English]
METHODS FOR TREATING GASTRIC CANCER
[French]
MÉTHODES DE TRAITEMENT DU CANCER GASTRIQUE
Applicants **
ANCHORDX MEDICAL CO., LTD.
Inventors
CHEN, Zhiwei
FAN, Jianbing
RUAN, Weimei
Priority Data
PCT/CN2022/074112
26.01.2022
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2365 | |
| EPO | Filing, Examination, Granting | 16172 | |
| Japan | Filing, Examination, Granting | 2337 | |
| South Korea | Filing, Examination, Granting | 2432 | |
| USA | Filing, Examination, Granting | 5190 |
Total:
28,496
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are methods for treating a subject having or suspected of having gastric cancer, and a therapeutic compound effective to regulate one or more genes, wherein the one or more genes are directly or indirectly regulated by a methylation sites disclosed herein.[French]
L'invention concerne des méthodes de traitement d'un sujet atteint ou suspecté d'être atteint d'un cancer gastrique, et un composé thérapeutique efficace pour réguler un ou plusieurs gènes, le ou les gènes étant régulés directement ou indirectement par un site de méthylation de l'invention.